| scholarly article | Q13442814 |
| P50 | author | Eduardo Melani Rocha | Q44439973 |
| P2093 | author name string | Leonardo Tannus Malki | |
| Peter S Reinach | |||
| Ellen Carrara Fonseca | |||
| Gustavo Viani Arruda | |||
| Monica Alves | |||
| Milena Freitas Alves | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | systematic review | Q1504425 |
| eye disease | Q3041498 | ||
| P304 | page(s) | 181-192 | |
| P577 | publication date | 2013-05-10 | |
| P1433 | published in | The Ocular Surface | Q15764153 |
| P1476 | title | Dry eye disease treatment: a systematic review of published trials and a critical appraisal of therapeutic strategies | |
| P478 | volume | 11 |
| Q89536714 | An Updated Systematic Review With Meta-Analysis Of Randomized Trials On Topical Cyclosporin A For Dry-Eye Disease |
| Q24561486 | Artificial tears potpourri: a literature review |
| Q36138820 | Bioengineered Lacrimal Gland Organ Regeneration in Vivo |
| Q38712838 | Burning Eye Syndrome: Do Neuropathic Pain Mechanisms Underlie Chronic Dry Eye? |
| Q33645315 | Comparison of diagnostic tests in distinct well-defined conditions related to dry eye disease |
| Q36656777 | Comparison of the Anti-Inflammatory Effects of Artificial Tears in a Rat Model of Corneal Scraping |
| Q38235721 | Current Approach to Dry Eye Disease. |
| Q36250852 | Dry Eye Signs and Symptoms Persist During Systemic Neutralization of IL-1β by Canakinumab or IL-17A by Secukinumab |
| Q98611558 | Dry eye in rheumatoid arthritis patients under TNF-inhibitors: conjunctival goblet cell as an early ocular biomarker |
| Q41045866 | Effect of human autologous serum and fetal bovine serum on human corneal epithelial cell viability, migration and proliferation in vitro |
| Q37245147 | Effect of human milk as a treatment for dry eye syndrome in a mouse model |
| Q46896696 | Effect of mistletoe combined with carboxymethyl cellulose on dry eye in postmenopausal women. |
| Q36137428 | Efficacy of a fixed combination of 0.09 % xanthan gum/0.1 % chondroitin sulfate preservative free vs polyethylene glycol/propylene glycol in subjects with dry eye disease: a multicenter randomized controlled trial |
| Q35177377 | Evidence for TRPA1 involvement in central neural mechanisms in a rat model of dry eye. |
| Q87383065 | Histopathological changes on the ocular surface of New Zealand white rabbits after instillation of a fixed combination of 0.09 % xanthan gum and 0.1 % chondroitin sulfate |
| Q51357621 | Immediate Effect of 3% Diquafosol Ophthalmic Solution on Tear MUC5AC Concentration and Corneal Wetting Ability in Normal and Experimental Keratoconjunctivitis Sicca Rat Models. |
| Q92669446 | Improvement of conjunctival cytological grade and tear production in Ankylosing Spondylitis patients under TNF inhibitors: a long-term follow-up |
| Q91706370 | Intense Pulsed Light Therapy In The Treatment Of Meibomian Gland Dysfunction: Current Perspectives |
| Q60047806 | Is Sjögren's syndrome dry eye similar to dry eye caused by other etiologies? Discriminating different diseases by dry eye tests |
| Q36494967 | Long-term Natural History of Dry Eye Disease from the Patient's Perspective |
| Q33752165 | Nanomolar-Potency Aminophenyl-1,3,5-triazine Activators of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Chloride Channel for Prosecretory Therapy of Dry Eye Diseases |
| Q24186110 | Over the counter (OTC) artificial tear drops for dry eye syndrome |
| Q52608828 | Patient and physician perspectives on the use of cyclosporine ophthalmic emulsion 0.05% for the management of chronic dry eye. |
| Q41615871 | Pro-Secretory Activity and Pharmacology in Rabbits of an Aminophenyl-1,3,5-Triazine CFTR Activator for Dry Eye Disorders |
| Q38584878 | Recommendations for the treatment of Sjögren's syndrome |
| Q91879800 | Reliability of the Evidence Addressing Treatment of Corneal Diseases: A Summary of Systematic Reviews |
| Q35472653 | Sensitization of trigeminal brainstem pathways in a model for tear deficient dry eye |
| Q36812082 | Small-molecule CFTR activators increase tear secretion and prevent experimental dry eye disease |
| Q38171801 | Systematic review of randomised clinical trials on topical ciclosporin A for the treatment of dry eye disease. |
| Q36921555 | Tear volume estimation using a modified Schirmer test: a randomized, multicenter, double-blind trial comparing 3% diquafosol ophthalmic solution and artificial tears in dry eye patients |
| Q38270449 | The role and treatment of inflammation in dry eye disease |
| Q48265701 | Trigeminal brainstem modulation of persistent orbicularis oculi muscle activity in a rat model of dry eye. |
| Q57479267 | Validation of an Objective Measure of Dry Eye Severity |
Search more.